IPCA Laboratories Ltd (IPCALAB)

Company profile

Sector

Pharmaceuticals

Industry

Pharmaceuticals & Biotechnology

Market cap (₹ Cr)

45,531.03

Ipca Laboratories Ltd. engages in the manufacture, research, and development of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 16,167 full-time employees. The firm is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. The company offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The firm offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The firm has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 1,903.5

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

42.32

52-week high

2,038

52-week low

1,251.6

Revenue CAGR, 3 years (%)

15.6

Revenue CAGR, 5 years (%)

12.22

EPS CAGR, 3 years (%)

34.27

EPS CAGR, 5 years (%)

0.02

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

44.72%

FII

10.63%

DII

37.45%

Public

7.2%

Promoter shares pledged

0%

Source: finedge · as of 2026-03-31

Similar companies

• GlaxoSmithKline Pharmaceuticals Ltd₹ 45,206 Cr
• Gland Pharma Ltd₹ 46,509.56 Cr
• Ajanta Pharma Ltd₹ 42,842.3 Cr
• JB Chemicals & Pharmaceuticals Ltd₹ 38,730.77 Cr
• Emcure Pharmaceuticals Ltd₹ 36,550.41 Cr
• Wockhardt Ltd₹ 33,525.38 Cr

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does IPCA Laboratories Ltd do?

Ipca Laboratories Ltd. engages in the manufacture, research, and development of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 16,167 full-time employees. The firm is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. The company offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The firm offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The firm has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.

Which sector is IPCA Laboratories Ltd in?

IPCA Laboratories Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.

What are IPCA Laboratories Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 9646.33 Cr, profit after tax 1141.12 Cr.

What is the promoter holding and pledge in IPCA Laboratories Ltd?

Promoter holding is 44.72%; pledged shares are 0.00% of the promoter holding.

Which companies are similar to IPCA Laboratories Ltd?

Companies in the same sector of similar size: GlaxoSmithKline Pharmaceuticals Ltd, Gland Pharma Ltd, Ajanta Pharma Ltd, JB Chemicals & Pharmaceuticals Ltd, Emcure Pharmaceuticals Ltd, Wockhardt Ltd.